---
title: "Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025  | DRMA Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280689839.md"
description: "Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025 | DRMA Stock News"
datetime: "2026-03-26T13:15:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280689839.md)
  - [en](https://longbridge.com/en/news/280689839.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280689839.md)
---

# Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025  | DRMA Stock News

Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025 | DRMA Stock News

### Related Stocks

- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [DRMA.US](https://longbridge.com/en/quote/DRMA.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [DRMAW.US](https://longbridge.com/en/quote/DRMAW.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)

## Related News & Research

- [Analyst Reiterates Buy on Dermata, Keeps 12-Month Price Target Unchanged at $4](https://longbridge.com/en/news/286958909.md)
- [Skye Bioscience opens higher-dose Cohort 2 in nimacimab obesity Phase 2a study](https://longbridge.com/en/news/287053007.md)
- [Acrivon Therapeutics, Inc. (ACRV) Receives a Buy from Oppenheimer](https://longbridge.com/en/news/286428001.md)
- [Relay's treatment shown to shrink vascular malformations in mid-stage trial](https://longbridge.com/en/news/286890329.md)
- [AbbVie Inc. $ABBV Shares Purchased by RiverFront Investment Group LLC](https://longbridge.com/en/news/286750290.md)